Cuba launches clinic for chikungunya aftereffects

The Institute of Neurology and Neurosurgery in Cuba has begun a specialized clinic to care for patients with post-chikungunya ailments, particularly those linked to neuropathic pain, joint pain, and paresthesia. This step provides focused treatment for individuals impacted by the mosquito-borne virus.

In Havana on December 23, the Institute of Neurology and Neurosurgery in Cuba has launched a specialized clinic dedicated to treating patients with post-chikungunya ailments. The facility focuses on conditions such as neuropathic pain, joint pain, and paresthesia, which are common lingering effects of the mosquito-borne chikungunya virus that causes fever and severe aches.

Chikungunya can lead to long-term complications that impair daily life for those infected. The new clinic aims to address these persistent issues through comprehensive care. As reported by Prensa Latina, this opening meets the demand for specialized health services in Cuba.

While specific patient numbers are not yet available, the clinic is part of Cuba's public health efforts to manage infectious diseases and their neurological aftermaths. This initiative highlights Cuba's dedication to accessible medical treatment for virus-related conditions.

Makala yanayohusiana

Comparative illustration of long COVID patients: US woman with severe brain fog and anxiety versus milder symptoms in India, Nigeria, and Colombia, per international study.
Picha iliyoundwa na AI

International study finds U.S. long COVID patients report more brain fog and psychological symptoms than peers in India and Nigeria

Imeripotiwa na AI Picha iliyoundwa na AI Imethibitishwa ukweli

A Northwestern Medicine-led study of more than 3,100 adults with long COVID found that non-hospitalized participants in the United States reported substantially higher rates of brain fog, depression/anxiety and insomnia than participants in Colombia, Nigeria and India—differences the researchers say likely reflect cultural factors and access to care as much as biology.

Cuban President Miguel Díaz-Canel presented preliminary positive results from clinical trials of the biotechnological drug Jusvinza in patients with chronic post-chikungunya arthritis. The studies, started in December 2025, show notable improvements in provinces like Havana and Matanzas. Experts highlight the drug's safety profile and potential to slow inflammation.

Imeripotiwa na AI

Cuba has a favorable epidemiological situation in its fight against arboviruses, following a 21 percent decrease in reported febrile cases last week. This improvement highlights effective efforts to control vector-borne diseases such as dengue and zika. Health authorities emphasize the need for ongoing vigilance.

Wizara ya Afya imewahadharisha Wanakenya dhidi ya kusafiri visivyo muhimu kwenda sehemu za India baada ya kuthibitishwa kwa visa viwili vya virusi vya Nipah huko West Bengal. Hatari ya kuenea kwa ugonjwa huu nchini Kenya ni ndogo, lakini wizara inashauri kufuata usafi mkubwa wa kibinafsi. Shirika la Afya Duniani limehakikisha mlipuko wa ugonjwa huu adimu lakini mbaya.

Imeripotiwa na AI

In Brazil's shrinking Atlantic Forest, deforestation is causing mosquitoes to increasingly feed on humans, heightening the risk of diseases like dengue and Zika. A new study reveals that out of identified blood meals, most came from people rather than wildlife. This adaptation underscores how habitat loss alters disease transmission patterns.

Researchers from Weill Cornell Medicine and Wake Forest University School of Medicine have identified a stress-response pathway in immune cells that is activated by chemotherapy and leads to painful nerve damage. In mice, blocking this pathway with a drug already in early-stage cancer trials reduced signs of nerve injury, and a small patient study suggests a blood test might one day predict who is most at risk.

Imeripotiwa na AI

The Don Benito Health Area has confirmed the death of a 15-year-old teenager from meningoencephalitis caused by reactivation of type 6 virus. The death occurred on March 13 at Vegas Altas hospital. Health authorities state that this variant does not require epidemiological surveillance or specific protocols.

Jumatano, 25. Mwezi wa tatu 2026, 15:51:45

Brazil and Peru advance high-tech tools against climate-driven dengue

Jumatano, 11. Mwezi wa tatu 2026, 08:54:47

Cuba withdraws doctors from Jamaica over new conditions

Alhamisi, 19. Mwezi wa pili 2026, 21:30:30

Challenges mark author's return to Cuba after three years

Jumatatu, 16. Mwezi wa pili 2026, 14:00:03

Cuba prioritizes development of pneumococcal vaccines

Ijumaa, 6. Mwezi wa pili 2026, 18:58:25

Cuba suspends hospital surgeries amid fuel crisis

Jumapili, 1. Mwezi wa pili 2026, 11:04:02

Lien Estrada describes health struggles amid Cuba's medicine shortage

Jumatano, 7. Mwezi wa kwanza 2026, 11:13:25

Cuba deploys immune shield for elderly against chikungunya

Ijumaa, 2. Mwezi wa kwanza 2026, 01:12:26

The dilemma Cubans face: food or medicines in Havana

Jumamosi, 13. Mwezi wa kumi na mbili 2025, 15:39:02

Spain recommends against travel to Cuba due to epidemics

Jumapili, 23. Mwezi wa kumi na moja 2025, 21:35:58

Researchers pinpoint enzyme that could enable safer pain relief

 

 

 

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa